HOME >> BIOLOGY >> NEWS
JCI table of contents: July 19, 2007

IMMUNOLOGY

Keeping killer T cells under control in the liver

Natural killer (NK) T cells (of which type I and type II exist) are a small group of T cells in the blood that recognize and bind self- and foreign lipids. They rapidly release cytokines that can promote or suppress different immune responses, however the regulation of these responses is not well understood. In a study appearing online on July 19 in advance of publication in the August print issue of the Journal of Clinical Investigation, Vipin Kumar and colleagues from the Torrey Pines Institute for Molecular Studies examined the responses of these cells following their recognition of a self-glycolipid, sulfatide, and their relevance to inflammatory liver disease. They show that activation of sulfatide-reactive type II NKT cells caused recruitment of type I NKT cells into the liver in mice. These recruited type I NKT cells were anergic (ie. they were not able to mount a normal immune response against this self antigen) and as such were able to prevent experimentally-induced hepatitis in these animals. The authors went on to show that secretion of the cytokine IL-12 by dendritic cells in the liver and interaction of these dendritic cells with type II NKT cells was able to regulate the activity of type I NKT cells. The authors suggest that this activity could be exploited for the purpose of devising therapeutic interventions for inflammatory disease, including autoimmune diseases and asthma.

TITLE: Type II NKT cellmediated anergy induction in type I NKT cells prevents inflammatory liver disease

AUTHOR CONTACT:
Vipin Kumar
Torrey Pines Institute for Molecular Studies, San Diego, California, USA.
Phone: (858) 455-3870; Fax: (858) 455-3804; E-mail: vkumar@tpims.org

View the PDF of this article at: https://www.the-jci.org/article.php?id=316
'"/>


Contact: Brooke Grindlinger
press_releases@the-jci.org
734-546-5242
Journal of Clinical Investigation
19-Jul-2007


Page: 1 2 3 4 5 6 7

Related biology news :

1. Antioxidant overload may underlie a heritable human disease
2. JCI table of contents: Aug. 9, 2007
3. JCI table of contents: August 1, 2007
4. US Department of Defense awards $1.6 million for implantable biochip research
5. More fish oil, less vegetable oil, better for your health
6. JCI table of contents -- July 26, 2007
7. JCI table of contents: July 12, 2007
8. JCI table of contents: June 21, 2007
9. JCI table of contents: June 14, 2007
10. Food safety begins as vegetables grow
11. Turning the tables in chemistry

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/10/2019)... DIEGO (PRWEB) , ... October 09, 2019 , ... ... merger-acquisition of Nanosens Innovations, Inc., the creators of CRISPR-Chip™. Cardea first broke ... of their Early Access Program for the Genome Sensor™. Built with CRISPR-Chip technology, ...
(Date:10/8/2019)... ... October 08, 2019 , ... ... the National Research Council of Canada (NRC) to create the Laboratory of ... technologies and in manufacturing, LIFT will offer a competitive capacity to accelerate ...
(Date:10/8/2019)... ... 07, 2019 , ... The future of medicine in the 21st century will ... living longer, healthier lives. But it will be up to each individual to make ... PhD, Chief Strategy Officer and Co-Founder of the Institute for Systems Biology and Senior ...
Breaking Biology News(10 mins):
(Date:10/8/2019)... ... October 08, 2019 , ... Today, Massachusetts stem cell ... lead development technology. Like the company’s precursor patent, approved in the U.S. in ... of tissue stem cells. Asymmetrex now markets the technology in the U.S. as ...
(Date:10/3/2019)... ... October 02, 2019 , ... Murrieta Genomics , the launch ... venture capital companies in Silicon Valley at a special Life Science showcase event ... be held at the JJ Lake Business Center located at 340 E. Middlefield Road ...
(Date:9/30/2019)... ... September 30, 2019 , ... The September 2019 edition of ... is now available online on the company’s global website. The Bridge features current ... fluorescence and imaging, and presents articles, scientific papers and news reports. , ...
(Date:9/24/2019)... ... September 24, 2019 , ... ... has completed training and site qualification for clinical trial sites and physician investigators. ... screening of potential clinical trial participants. , Clinical trial sites are currently located ...
Breaking Biology Technology:
Cached News: